GRAS Notices
-
GRN No. 265
Glycerophospholipid cholesterol acyltransferase (GCAT) enzyme preparation from Bacillus licheniformis expressing a modified GCAT gene from Aeromonas salmonicida subsp. salmonicida
Intended Use: |
As an enzyme to modify phospholipids to lyso-phospholipids and cholesterol ester in egg yolks to avoid product separation during mayonnaise production; processed meat products for emulsification, better consistency, and reduced cooking loss; cheese for increased yield; eggs to give a softer and more tender crumb in bakery products, and degumming of vegetable oils As an enzyme in the production of ultra-high temperature processed milk, powdered milk, and yogurt at concentrations ranging from 0.38 to 1.5 milligrams total organic solids per kilogram of food |
---|---|
Basis: | Scientific procedures |
Notifier: | Genencor, a Danisco Division |
Notifier Address: |
Genencor, a Danisco Division 925 Page Mill Road Palo Alto, CA 94304 |
Date of filing: | Nov 7, 2008 |
GRAS Notice (releasable information): | GRN 265 (in PDF) |
Date of closure: | Jun 13, 2009 |
FDA's Letter: | FDA has no questions |
Additional correspondence: | Jul 15, 2010 |
Additional correspondence about intended use |
-